Furthermore, the expression of DNAM-1 was decreased in NK cells from acute myeloid leukemia patients and it was negatively correlated with the expression of CD112 in blasts [43] supporting that DNAM-1 downregulation on NK cells in patients with cancer, is a consequence of the tumor burden. The gene discussed is NECTIN2; the disease is neoplasm.